Menu
GeneBe

KISS1

KiSS-1 metastasis suppressor, the group of Neuropeptides

Basic information

Region (hg38): 1:204190340-204196491

Links

ENSG00000170498NCBI:3814OMIM:603286HGNC:6341Uniprot:Q15726AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • hypogonadotropic hypogonadism (Supportive), mode of inheritance: AD
  • hypogonadotropic hypogonadism 13 with or without anosmia (Limited), mode of inheritance: AR
  • hypogonadotropic hypogonadism 13 with or without anosmia (Limited), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Hypogonadotropic hypogonadism 13 with or without anosmiaAREndocrineIn Hypogonadotropic hypogonadism, surveillance in adolescence related to sexual maturation is indicated, as is monitoring of bone mineral density in order to allow early detection and treatment of disease; In order to induce and maintain secondary sex characteristics, gradually increasing doses of gonadal steroids (females: estrogen/progestin; males: testosterone/hCG) can be beneficial; Related to fertility, endocrinologic therapy (females: recombinant hCG or pulsatile GnRH therapy; males: hCG/HMG/recombinant FSH or pulsatile GnRH therapy) may be effective, though IVF may be requiredEndocrine; Neurologic20301509; 22335740

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the KISS1 gene.

  • not provided (29 variants)
  • Inborn genetic diseases (7 variants)
  • not specified (3 variants)
  • Hypogonadotropic hypogonadism 13 with or without anosmia (3 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the KISS1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
5
clinvar
1
clinvar
6
missense
10
clinvar
2
clinvar
4
clinvar
16
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
11
clinvar
12
Total 0 0 10 8 16

Variants in KISS1

This is a list of pathogenic ClinVar variants found in the KISS1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-204190409-T-TTG Benign (Jun 19, 2018)1258690
1-204190411-C-G Benign (Oct 31, 2018)1267581
1-204190413-CG-C Benign (Jun 19, 2018)1247896
1-204190414-G-C Benign (Jul 09, 2018)1291541
1-204190416-C-CA Benign (Aug 07, 2018)1225438
1-204190474-A-ACCTGCGCCCTCAGCCCCGCC Benign (May 25, 2021)1226970
1-204190483-CT-C not specified • Hypogonadotropic hypogonadism 13 with or without anosmia Benign (Jan 29, 2024)403018
1-204190526-C-T Likely benign (Apr 09, 2018)738996
1-204190534-T-C not specified Uncertain significance (Nov 21, 2023)3115177
1-204190552-A-G Uncertain significance (Oct 03, 2023)1303092
1-204190561-A-T not specified Uncertain significance (Oct 03, 2023)3115176
1-204190562-G-C Hypogonadotropic hypogonadism 13 with or without anosmia Pathogenic (Feb 16, 2012)30349
1-204190571-C-T Likely benign (Aug 23, 2022)2189884
1-204190573-G-T Benign (Jan 18, 2024)716738
1-204190608-T-A not specified Uncertain significance (May 23, 2023)2550334
1-204190616-G-A Benign (Dec 21, 2021)2082646
1-204190618-G-A Disorder of sexual differentiation Uncertain significance (Sep 01, 2021)1342171
1-204190633-G-A Uncertain significance (Apr 17, 2023)2895951
1-204190633-G-C not specified • Hypogonadotropic hypogonadism 13 with or without anosmia Benign/Likely benign (Oct 22, 2023)501504
1-204190634-G-T Likely benign (Mar 30, 2018)734700
1-204190638-G-C not specified Uncertain significance (Mar 01, 2023)1899431
1-204190647-C-T Uncertain significance (Dec 14, 2021)2120171
1-204190659-G-C not specified • Hypogonadotropic hypogonadism 13 with or without anosmia Benign (Jan 31, 2024)1174871
1-204190661-G-A KISS1-related disorder Likely benign (Mar 06, 2019)3058712
1-204190671-C-T Uncertain significance (Apr 29, 2022)2131989

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
KISS1protein_codingprotein_codingENST00000367194 26146
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.4900.43800000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.09647774.71.030.00000334829
Missense in Polyphen2017.9391.1149171
Synonymous-0.7254337.41.150.00000175305
Loss of Function1.2601.850.007.91e-819

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Metastasis suppressor protein in malignant melanomas and in some breast cancers. May regulate events downstream of cell- matrix adhesion, perhaps involving cytoskeletal reorganization. Generates a C-terminally amidated peptide, metastin which functions as the endogenous ligand of the G-protein coupled receptor GPR54. Activation of the receptor inhibits cell proliferation and cell migration, key characteristics of tumor metastasis. Kp-10 is a decapeptide derived from the primary translation product, isolated in conditioned medium of first trimester trophoblast. Kp-10, but not other kisspeptins, increased intracellular Ca(2+) levels in isolated first trimester trophoblasts. Kp-10 is a paracrine/endocrine regulator in fine- tuning trophoblast invasion generated by the trophoblast itself. The receptor is also essential for normal gonadotropin-released hormone physiology and for puberty. The hypothalamic KiSS1/GPR54 system is a pivotal factor in central regulation of the gonadotropic axis at puberty and in adulthood. {ECO:0000269|PubMed:11060311, ECO:0000269|PubMed:11385580, ECO:0000269|PubMed:15500545, ECO:0000269|PubMed:9185708}.;
Disease
DISEASE: Hypogonadotropic hypogonadism 13 with or without anosmia (HH13) [MIM:614842]: A disorder characterized by absent or incomplete sexual maturation by the age of 18 years, in conjunction with low levels of circulating gonadotropins and testosterone and no other abnormalities of the hypothalamic- pituitary axis. In some cases, it is associated with non- reproductive phenotypes, such as anosmia, cleft palate, and sensorineural hearing loss. Anosmia or hyposmia is related to the absence or hypoplasia of the olfactory bulbs and tracts. Hypogonadism is due to deficiency in gonadotropin-releasing hormone and probably results from a failure of embryonic migration of gonadotropin-releasing hormone-synthesizing neurons. In the presence of anosmia, idiopathic hypogonadotropic hypogonadism is referred to as Kallmann syndrome, whereas in the presence of a normal sense of smell, it has been termed normosmic idiopathic hypogonadotropic hypogonadism (nIHH). {ECO:0000269|PubMed:22335740}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Signaling by GPCR;Signal Transduction;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (q) signalling events;GPCR downstream signalling (Consensus)

Recessive Scores

pRec
0.156

Haploinsufficiency Scores

pHI
0.0423
hipred
N
hipred_score
0.146
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.743

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Kiss1
Phenotype
homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; reproductive system phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; renal/urinary system phenotype; liver/biliary system phenotype;

Zebrafish Information Network

Gene name
kiss1
Affected structure
raphe nucleus
Phenotype tag
abnormal
Phenotype quality
process quality

Gene ontology

Biological process
cytoskeleton organization;G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;negative regulation of cell population proliferation;positive regulation of luteinizing hormone secretion;positive regulation of MAPK cascade;positive regulation of synaptic transmission;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway;generation of ovulation cycle rhythm;positive regulation of growth hormone secretion
Cellular component
extracellular region;extracellular space;cytoplasm;apical plasma membrane;neuron projection;neuronal cell body
Molecular function
protein binding;kisspeptin receptor binding